The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Monoclonal Antibody Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
The global Monoclonal Antibody Therapeutics market size is expected to reach US$ 190750 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibody Therapeutics in various end use industries. The expanding demands from the Cancer, Autoimmune Diseases, Infection and Hematological Diseases, are propelling Monoclonal Antibody Therapeutics market. Humanized Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Mouse Chimeric Antibody segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Monoclonal Antibody Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Monoclonal Antibody Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibody Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibody Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibody Therapeutics covered in this report include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc.
The global Monoclonal Antibody Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen
Global Monoclonal Antibody Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Therapeutics market, Segment by Type:
Humanized Antibody
Human Mouse Chimeric Antibody
Global Monoclonal Antibody Therapeutics market, by Application
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Monoclonal Antibody Therapeutics market size is expected to reach US$ 190750 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibody Therapeutics in various end use industries. The expanding demands from the Cancer, Autoimmune Diseases, Infection and Hematological Diseases, are propelling Monoclonal Antibody Therapeutics market. Humanized Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Mouse Chimeric Antibody segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Monoclonal Antibody Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Monoclonal Antibody Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibody Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibody Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibody Therapeutics covered in this report include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc.
The global Monoclonal Antibody Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen
Global Monoclonal Antibody Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Therapeutics market, Segment by Type:
Humanized Antibody
Human Mouse Chimeric Antibody
Global Monoclonal Antibody Therapeutics market, by Application
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Monoclonal Antibody Therapeutics
1.1 Monoclonal Antibody Therapeutics Market Overview
1.1.1 Monoclonal Antibody Therapeutics Product Scope
1.1.2 Monoclonal Antibody Therapeutics Market Status and Outlook
1.2 Global Monoclonal Antibody Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Monoclonal Antibody Therapeutics Market Size by Region (2018-2029)
1.4 Global Monoclonal Antibody Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Monoclonal Antibody Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Monoclonal Antibody Therapeutics Market Size (2018-2029)
1.6.1 North America Monoclonal Antibody Therapeutics Market Size (2018-2029)
1.6.2 Europe Monoclonal Antibody Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2018-2029)
1.6.4 Latin America Monoclonal Antibody Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2018-2029)
2 Monoclonal Antibody Therapeutics Market by Type
2.1 Introduction
2.1.1 Humanized Antibody
2.1.2 Human Mouse Chimeric Antibody
2.2 Global Monoclonal Antibody Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
3 Monoclonal Antibody Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Autoimmune Diseases
3.1.3 Infection
3.1.4 Hematological Diseases
3.1.5 Ophthalmological Diseases
3.1.6 Others
3.2 Global Monoclonal Antibody Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
4 Monoclonal Antibody Therapeutics Competition Analysis by Players
4.1 Global Monoclonal Antibody Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2022)
4.3 Date of Key Players Enter into Monoclonal Antibody Therapeutics Market
4.4 Global Top Players Monoclonal Antibody Therapeutics Headquarters and Area Served
4.5 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Monoclonal Antibody Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Monoclonal Antibody Therapeutics Products, Services and Solutions
5.1.4 Bayer Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Monoclonal Antibody Therapeutics Products, Services and Solutions
5.3.4 Pfizer Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Monoclonal Antibody Therapeutics Products, Services and Solutions
5.4.4 Sanofi Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Products, Services and Solutions
5.5.4 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Monoclonal Antibody Therapeutics Products, Services and Solutions
5.6.4 Merck Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Monoclonal Antibody Therapeutics Products, Services and Solutions
5.7.4 Novartis Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Monoclonal Antibody Therapeutics Products, Services and Solutions
5.8.4 AbbVie Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 AbbVie Recent Developments
5.9 Amgen
5.9.1 Amgen Profile
5.9.2 Amgen Main Business
5.9.3 Amgen Monoclonal Antibody Therapeutics Products, Services and Solutions
5.9.4 Amgen Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Amgen Recent Developments
5.10 Johnson & Johnson
5.10.1 Johnson & Johnson Profile
5.10.2 Johnson & Johnson Main Business
5.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Products, Services and Solutions
5.10.4 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Johnson & Johnson Recent Developments
5.11 Bristol-Myers Squibb Company
5.11.1 Bristol-Myers Squibb Company Profile
5.11.2 Bristol-Myers Squibb Company Main Business
5.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Products, Services and Solutions
5.11.4 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Bristol-Myers Squibb Company Recent Developments
5.12 Biogen
5.12.1 Biogen Profile
5.12.2 Biogen Main Business
5.12.3 Biogen Monoclonal Antibody Therapeutics Products, Services and Solutions
5.12.4 Biogen Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Biogen Recent Developments
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monoclonal Antibody Therapeutics Market Dynamics
11.1 Monoclonal Antibody Therapeutics Industry Trends
11.2 Monoclonal Antibody Therapeutics Market Drivers
11.3 Monoclonal Antibody Therapeutics Market Challenges
11.4 Monoclonal Antibody Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
